Fibrosis regression in chronic liver disease: the pathologist&apos;s view

Further Publications

Role of Prucalopride in the Treatment of Chronic Constipation in Parkinson's Disease: A Randomized Controlled Trial

Am J Gastroenterol

Preechakawin N, Maneerattanaporn M, Geeratragool T, Srivanitchapoom P, Pitakpatapee Y, Leelakusolvong S

doi: 10.14309/ajg.0000000000003771

Hepatology

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease

J Gastroenterol Hepatol

Hsieh ML, Su TH, Lin YC, Chen YY, Tung CF, Huang LS, Wu CH, Peng YC, Hsieh VC

doi: 10.1111/jgh.70259

Pancreas Diseases

Robotic versus open Frey's procedure for chronic pancreatitis: a single center's experience of 40 cases over a 7-year period

BMC Gastroenterol

Li W, Cheng Y, Yang X, Ma Q, Wu Z, Wang Z

doi: 10.1186/s12876-026-04790-w

Inflammatory Bowel Disease

Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study

Clin Gastroenterol Hepatol

Wewer MD, Lophaven S, Lakatos PL, Gonczi L, Salupere R, Linda Kievit HA, Nielsen KR, Midjord J, Domislovic V, Krznarić Ž, Pedersen N, Kjeldsen J, Halfvarson J, Sebastian S, Goldis A, Arebi N, Oksanen P, Neumann A, Andersen V, Katsanos KH, Koukoudis A, Turcan S, Ellul P, Kupcinskas J, Kiudelis G, Fumery M, Kaimakliotis IP, D'Inca R, Lombardini S, Hernandez V, Fernandez A, Langholz E, Munkholm P, Burisch J, Epi-IBD-group.

doi: 10.1016/j.cgh.2025.10.022

Hepatology

Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis

Lancet Gastroenterol Hepatol

Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, Targher G, Krag A, Rinella ME, Cammà C, Petta S

doi: 10.1016/S2468-1253(25)00188-8

Inflammatory Bowel Disease

Real-World Effectiveness of Upadacitinib for Perianal Crohn's Disease: A Multi-Center Retrospective Study

Clin Gastroenterol Hepatol

Devi J, Patel A, Quraishi B, Dev B, Tan T, Kline M, Chowla N, Ramesh PR, Ballard DH, Huang L, Jaiprada F, Samaan S, Stone M, Khan A, Seeraj AA, Alanazi S, Xu A, Maas L, Jajoo A, Parian A, Altinmakas E, Ehman EC, Davenport MS, Li S, Chithriki M, Shukla R, McCurdy J, Yarur AJ, Bishu S, Johnson AM, Benjamin M, Dulaney D, Serre-Yu W, Deepak P

doi: 10.1016/j.cgh.2026.05.003

Inflammatory Bowel Disease

Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey

J Crohns Colitis

Moreira PL, Dignass A, Estevinho MM, Santiago M, Reinisch W, Sands BE, D'Haens G, Mantzaris GJ, Danese S, Peyrin-Biroulet L, Dotan I, Jairath V, Magro F, International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)

doi: 10.1093/ecco-jcc/jjaf178

Inflammatory Bowel Disease

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

United European Gastroenterol J

Mañosa M, Calafat M, Ricart E, Nos P, Iglesias E, Riestra S, Mesonero F, Calvo M, Guardiola J, Hernández V, Rivero M, Carpio D, Mínguez M, Alba C, Martín-Arranz MD, Vela M, Gomollón F, García-López S, Casbas AG, Calvet X, González-Muñoza C, Barrio J, Gisbert JP, Sicilia B, Pérez-Calle JL, Bujanda L, Esteve M, Ramos L, Varela P, Sierra M, Merino O, Bermejo F, Acosta MB, Perez AR, Márquez-Mosquera L, García-Bosch O, Rodríguez-Lago I, Lorente Poyatos RH, García Sepulcre MF, Maroto N, Vega P, Monfort D, San Martín LZ, Busquets D, Martinez-Montiel P, Riera J, Alcain G, Llaó J, Marin N, Marin-Jimenez I, Sesé E, Van Domselaar M, Huguet JM, Ginard D, Bas-Cutrina F, Ber Y, Roncero O, Lucendo AJ, López-García A, Menacho M, Almela P, Ponferrada Á, Coronel AF, Maestro S, de Jesús Martínez-Pérez T, Vilafranca CM, Argüelles F, Legido J, Gilabert P, Charro M, Trapero AM, Fernández H, Frago S, Villalba LH, Muñoz E, Domènech E, ENEIDA registry of GETECCU

doi: 10.1002/ueg2.70150

Inflammatory Bowel Disease

Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges

Inflamm Bowel Dis

Jairath V, Adsul S, Allocca M, Danese S, Dubinsky MC, de Oliveira MF, Ma C, Kucharzik T, Novak KL, Panaccione R, Bautista IR, Sands BE, Taylor SA, Wilkens R, Maaser C

doi: 10.1093/ibd/izaf196

Gastroenterology

Fibrosis regression in chronic liver disease: the pathologist's view

Related content

Role of Prucalopride in the Treatment of Chronic Constipation in Parkinson's Disease: A Randomized Controlled Trial

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease

Robotic versus open Frey's procedure for chronic pancreatitis: a single center's experience of 40 cases over a 7-year period

Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study

Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis

Real-World Effectiveness of Upadacitinib for Perianal Crohn's Disease: A Multi-Center Retrospective Study

Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges